The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice
Open accessAbstract
Transgenic mice expressing human insulin-like growth factor 1 (IGF-1) in basal epithelial cells of prostate have been characterized. Transgene expression led to activation of the IGF-1 receptor and spontaneous tumorigenesis in prostate epithelium. Hyperplasia was evident in these mice by 2–3 months of age. Atypical hyperplasias and prostatic intraepithelial neoplasia were evident by 6–7 months of age. Well differentiated adenocarcinomas appeared in mice 6 months or older. Less differentiated tumors, diagnosed as small cell carcinomas, were also observed in two of the older mice. Both lobes of the mouse prostate gland (dorsolateral and ventral) presented preneoplastic and neoplastic changes. The incidence of tumors in mice ≥6 months of age (38 mice total) was 50%. The development of neoplasia in these transgenic mice appeared to follow a stepwise progression through early preneoplastic changes that ultimately culminated in frank neoplasia. These mice offer an animal model for prostate cancer that will allow study of the stepwise development of this disease and the mechanism(s) whereby IGF-1 mediates this process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710
Aaronson, S. A. (1991) · Science · doi:10.1126/science.1659742 · Cited by 2,028
Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1997) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.47.1.5 · Cited by 2,003
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Sunburn and p53 in the onset of skin cancer
Ziegler, A., Jonason, A. S., Leffellt, D. J., Simon, J. A., Sharma, H. W., Kimmelman, J., Remington, L., Jacks, T., & Brash, D. E. (1994) · Nature · doi:10.1038/372773a0 · Cited by 1,497
Prostate cancer in a transgenic mouse.
Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., & Rosen, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3439 · Cited by 1,294
Rajah, R., Valentinis, B., & Cohen, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12181 · Cited by 722
The insulin-like growth factor I receptor: a key to tumor growth?
Baserga, R. (1995) · PubMed · Cited by 552
Growth Enhancement of Transgenic Mice Expressing Human Insulin-Like Growth Factor I*
MATHEWS, L. S., HAMMER, R. E., BEHRINGER, R. R., D'ERCOLE, A. J., BELL, G. I., BRINSTER, R. L., & PALMITER, R. D. (1988) · Endocrinology · doi:10.1210/endo-123-6-2827 · Cited by 477
The IGF-I receptor in cell growth, transformation and apoptosis
Baserga, R., Hongo, A., Rubini, M., Prisco, M., & Valentinis, B. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00007-3 · Cited by 439
Sequence of cDNA encoding human insulin-like growth factor I precursor
Jansen, M., van Schaik, F. M. A., Ricker, A. T., Bullock, B., Woods, D. E., Gabbay, K. H., Nussbaum, A. L., Sussenbach, J. S., & Van den Brande, J. L. (1983) · Nature · doi:10.1038/306609a0 · Cited by 396
Maroulakou, I. G., Anver, M., Garrett, L., & Green, J. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11236 · Cited by 363
COHEN, P., PEEHL, D. M., LAMSON, G., & ROSENFELD, R. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-401 · Cited by 355
Regulation of prostatic growth and function by peptide growth factors
Culig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Hittmair, A., Zhang, J., Thurnher, M., Bartsch, G., & Klocker, H. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199606)28:6<392::aid-pros9>3.0.co;2-c · Cited by 307
English, H. F., Kyprianou, N., & Isaacs, J. T. (1989) · The Prostate · doi:10.1002/pros.2990150304 · Cited by 273
Rogler, C. E., Yang, D., Rossetti, L., Donohoe, J., Alt, E., Chang, C. J., Rosenfeld, R., Neely, K., & Hintz, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36715-7 · Cited by 272
Ramírez, A., Bravo, A., Jorcano, J. L., & Vidal, M. (1994) · Differentiation · doi:10.1046/j.1432-0436.1994.5810053.x · Cited by 206
Self-citationEldridge, S. R., Tilbury, L. F., Goldsworthy, T. L., & Butterworth, B. (1990) · Carcinogenesis · doi:10.1093/carcin/11.12.2245 · Cited by 206
DiGiovanni, J., Bol, D. K., Wilker, E., Beltrán, L., Carbajal, S., Moats, S., Ramı́rez, Á., Jorcano, J. L., & Kiguchi, K. (2000) · PubMed · Cited by 177
Self-citationA transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells
Garabedian, E. M., Humphrey, P. A., & Gordon, J. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15382 · Cited by 177
Robles, A. I., Larcher, F., Whalin, R. B., Murillas, R., Richie, E., Gimenez-Conti, I. B., Jorcano, J. L., & Conti, C. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7634 · Cited by 177
Self-citationVerhagen, A. P. M., Aalders, T. W., Ramaekers, F. C. S., Debruyne, F. M. J., & Schalken, J. A. (1988) · The Prostate · doi:10.1002/pros.2990130104 · Cited by 175
Barreca, A., Luca, M. D., Monte, P. D., Bondanza, S., Damonte, G., Cariola, G., Marco, E. D., Giordano, G., Cancedda, R., & Minuto, F. M. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041510207 · Cited by 157
Timsit, J., Savino, W., Safieh‐Garabedian, B., Chanson, P., Gagnerault, M., Bach, J., & Dardenne, M. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.1.1619008 · Cited by 155
Bol, D. K., Kiguchi, K., Gimenez-Conti, I. B., Rupp, T., & DiGiovanni, J. (1997) · Oncogene · doi:10.1038/sj.onc.1201011 · Cited by 154
Self-citationE2F1 Has Both Oncogenic and Tumor-Suppressive Properties in a Transgenic Model
Pierce, A. M., Schneider‐Broussard, R., Gimenez-Conti, I. B., Russell, J. L., Conti, C. J., & Johnson, D. G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6408 · Cited by 151
Self-citationDisproportionate growth in mice with Igf-2 transgenes.
Ward, A., Bates, P., Fisher, R., Richardson, L., & Graham, C. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10365 · Cited by 102
Lobe-specific apoptotic cell death in rat prostate after androgen ablation by castration.
Banerjee, P. P., Banerjee, S., Tilly, K. I., et al. (1995) · Endocrinology · doi:10.1210/endo.136.10.7664656 · Cited by 92
Casatorres, J., Navarro, M., Blessing, M., & Jorcano, J. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32019-7 · Cited by 78
Self-citationProstate cancer progression, metastasis, and gene expression in transgenic mice.
Perez‐Stable, C., Altman, N. H., Mehta, P. P., Deftos, L. J., & Roos, B. A. (1997) · PubMed · Cited by 78
Dlugosz, A., Cheng, C., Denning, M. F., Dempsey, P. J., Coffey, R., & Yuspa, S. (1994) · PubMed · Cited by 78
Regulation of Apoptosis in the Prostate Gland by Androgenic Steroids
Buttyan, R., Shabsigh, A., Perlman, H., & Colombel, M. C. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00104-0 · Cited by 68
Peptide Growth Factors and Prostate Cancer: New Models, New Opportunities
Foster, B. A., Kaplan, P. J., & Greenberg, N. M. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006162410436 · Cited by 45
Chemical and hormonal induction of prostate cancer in animal models
Bosland, M. C. (1996) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/s1078-1439(97)82840-2 · Cited by 42
The insulin-like growth factor-I receptor and apoptosis: Implications for the aging progress
Roith, D. L., Párrizas, M., & Blakesley, V. A. (1997) · Endocrine · doi:10.1007/bf02778074 · Cited by 37
Tumor promoting activity of 1,8-dihydroxy-3-methyl-9-anthrone (chrysarobin) in female SENCAR mice
DiGiovanni, J., & Boutwell, R. K. (1983) · Carcinogenesis · doi:10.1093/carcin/4.3.281 · Cited by 29
Self-citation
Cited by
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 1,005
Molecular mechanisms of cancer development in obesity
Khandekar, M. J., Cohen, P., & Spiegelman, B. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3174 · Cited by 907
Obesity and cancer—mechanisms underlying tumour progression and recurrence
Park, J., Morley, T. S., Kim, M., Clegg, D. J., & Scherer, P. E. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.94 · Cited by 790
Metadata
- Authors
- DiGiovanni, J., Kiguchi, K., Frijhoff, A., Wilker, E., Bol, D. K., Beltrán, L., Moats, S., Ramirez, A., Jorcano, J., & Conti, C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-03-28
- Volume
- 97
- Issue
- 7
- Pages
- 3455-3460
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2010013468
- Cited by
- 281
- References
- 36
- FWCI
- 16.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.